Jade Biosciences Inc. (JBIO)
NASDAQ · Healthcare
Jade Biosciences Inc. Operating Income 2025–2025
Jade Biosciences Inc. annual/quarterly operating income history and growth rate from 2025 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Jade Biosciences Inc. operating income for the quarter ending March 31, 2026 was -43.4 M.
- Jade Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -133.6 M.
- Jade Biosciences Inc. annual operating income for 2025 was -113.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. Operating Income — FAQ
Jade Biosciences Inc. (JBIO) operating income over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Jade Biosciences Inc.'s operating income?
Jade Biosciences Inc. (JBIO) reported operating income of -$114M for fiscal 2025.
Where can I see JBIO's operating income history?
The chart and table above show Jade Biosciences Inc.'s operating income by year and by quarter, including the growth rate.